vs
Farmland Partners Inc.(FPI)与STANDARD BIOTOOLS INC.(LAB)财务数据对比。点击上方公司名可切换其他公司
Farmland Partners Inc.的季度营收约是STANDARD BIOTOOLS INC.的1.1倍($20.7M vs $19.6M),Farmland Partners Inc.净利率更高(103.4% vs -177.4%,领先280.8%),Farmland Partners Inc.同比增速更快(-3.5% vs -11.5%),过去两年Farmland Partners Inc.的营收复合增速更高(31.4% vs -12.2%)
农场土地工业曾是北美规模最大的农业合作社,在2002年至2004年间完成了全部资产出售。在其74年的经营历史中,该合作社作为多元化综合型机构为农户会员提供服务,在北美本土及全球农业市场都发挥过重要作用。
Standard BioTools(原Fluidigm公司)是一家美国生命科学工具企业,主营流式细胞术与组织成像分析用质谱流式系统,以及配套的检测试剂盒与试剂,同时供应自动化基因组分析仪器、各类微流控芯片(又称集成流体电路)及配套试剂耗材,全系列产品及应用场景均可提供定制检测方案与相关服务。
FPI vs LAB — 直观对比
营收规模更大
FPI
是对方的1.1倍
$19.6M
营收增速更快
FPI
高出7.9%
-11.5%
净利率更高
FPI
高出280.8%
-177.4%
两年增速更快
FPI
近两年复合增速
-12.2%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $20.7M | $19.6M |
| 净利润 | $21.4M | $-34.7M |
| 毛利率 | — | 48.5% |
| 营业利润率 | — | -168.5% |
| 净利率 | 103.4% | -177.4% |
| 营收同比 | -3.5% | -11.5% |
| 净利润同比 | -63.5% | -28.8% |
| 每股收益(稀释后) | $0.44 | $-0.09 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FPI
LAB
| Q4 25 | $20.7M | — | ||
| Q3 25 | $11.3M | $19.6M | ||
| Q2 25 | $10.0M | $21.8M | ||
| Q1 25 | $10.3M | $40.8M | ||
| Q4 24 | $21.5M | — | ||
| Q3 24 | $13.3M | $22.1M | ||
| Q2 24 | $11.4M | $22.5M | ||
| Q1 24 | $12.0M | $45.5M |
净利润
FPI
LAB
| Q4 25 | $21.4M | — | ||
| Q3 25 | $483.0K | $-34.7M | ||
| Q2 25 | $7.6M | $-33.5M | ||
| Q1 25 | $2.0M | $-26.0M | ||
| Q4 24 | $58.7M | — | ||
| Q3 24 | $1.8M | $-26.9M | ||
| Q2 24 | $-2.0M | $-45.7M | ||
| Q1 24 | $1.4M | $-32.2M |
毛利率
FPI
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | 48.5% | ||
| Q2 25 | — | 48.8% | ||
| Q1 25 | — | 48.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 54.9% | ||
| Q2 24 | — | 46.1% | ||
| Q1 24 | — | 53.1% |
营业利润率
FPI
LAB
| Q4 25 | — | — | ||
| Q3 25 | 4.3% | -168.5% | ||
| Q2 25 | 78.2% | -118.1% | ||
| Q1 25 | 20.6% | -80.8% | ||
| Q4 24 | — | — | ||
| Q3 24 | 13.9% | -120.9% | ||
| Q2 24 | -17.9% | -134.5% | ||
| Q1 24 | 11.9% | -132.2% |
净利率
FPI
LAB
| Q4 25 | 103.4% | — | ||
| Q3 25 | 4.3% | -177.4% | ||
| Q2 25 | 76.3% | -153.7% | ||
| Q1 25 | 19.9% | -63.8% | ||
| Q4 24 | 273.6% | — | ||
| Q3 24 | 13.5% | -122.0% | ||
| Q2 24 | -17.5% | -203.3% | ||
| Q1 24 | 11.5% | -70.6% |
每股收益(稀释后)
FPI
LAB
| Q4 25 | $0.44 | — | ||
| Q3 25 | $0.00 | $-0.09 | ||
| Q2 25 | $0.14 | $-0.09 | ||
| Q1 25 | $0.03 | $-0.07 | ||
| Q4 24 | $1.09 | — | ||
| Q3 24 | $0.02 | $-0.07 | ||
| Q2 24 | $-0.06 | $-0.12 | ||
| Q1 24 | $0.01 | $-0.27 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $129.4M |
| 总债务越低越好 | $161.6M | — |
| 股东权益账面价值 | $467.4M | $399.7M |
| 总资产 | $719.1M | $539.6M |
| 负债/权益比越低杠杆越低 | 0.35× | — |
8季度趋势,按日历期对齐
现金及短期投资
FPI
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | $129.4M | ||
| Q2 25 | — | $158.6M | ||
| Q1 25 | — | $150.9M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $210.6M | ||
| Q2 24 | — | $269.8M | ||
| Q1 24 | — | $287.1M |
总债务
FPI
LAB
| Q4 25 | $161.6M | — | ||
| Q3 25 | $170.4M | — | ||
| Q2 25 | $193.4M | — | ||
| Q1 25 | $202.6M | — | ||
| Q4 24 | $204.6M | — | ||
| Q3 24 | $394.0M | $55.2M | ||
| Q2 24 | $393.0M | $55.1M | ||
| Q1 24 | $383.0M | $55.0M |
股东权益
FPI
LAB
| Q4 25 | $467.4M | — | ||
| Q3 25 | $457.3M | $399.7M | ||
| Q2 25 | $473.5M | $424.5M | ||
| Q1 25 | $492.2M | $454.6M | ||
| Q4 24 | $494.6M | — | ||
| Q3 24 | $519.4M | $489.3M | ||
| Q2 24 | $521.5M | $510.3M | ||
| Q1 24 | $526.7M | $577.3M |
总资产
FPI
LAB
| Q4 25 | $719.1M | — | ||
| Q3 25 | $738.5M | $539.6M | ||
| Q2 25 | $776.7M | $557.0M | ||
| Q1 25 | $810.5M | $579.6M | ||
| Q4 24 | $869.6M | — | ||
| Q3 24 | $1.0B | $681.5M | ||
| Q2 24 | $1.0B | $708.7M | ||
| Q1 24 | $1.0B | $777.7M |
负债/权益比
FPI
LAB
| Q4 25 | 0.35× | — | ||
| Q3 25 | 0.37× | — | ||
| Q2 25 | 0.41× | — | ||
| Q1 25 | 0.41× | — | ||
| Q4 24 | 0.41× | — | ||
| Q3 24 | 0.76× | 0.11× | ||
| Q2 24 | 0.75× | 0.11× | ||
| Q1 24 | 0.73× | 0.10× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $17.4M | $-22.2M |
| 自由现金流经营现金流 - 资本支出 | — | $-23.1M |
| 自由现金流率自由现金流/营收 | — | -118.1% |
| 资本支出强度资本支出/营收 | — | 4.5% |
| 现金转化率经营现金流/净利润 | 0.81× | — |
| 过去12个月自由现金流最近4个季度 | — | $-111.1M |
8季度趋势,按日历期对齐
经营现金流
FPI
LAB
| Q4 25 | $17.4M | — | ||
| Q3 25 | $-2.0M | $-22.2M | ||
| Q2 25 | $-2.2M | $-20.7M | ||
| Q1 25 | $6.4M | $-30.3M | ||
| Q4 24 | $16.1M | — | ||
| Q3 24 | $-4.3M | $-27.9M | ||
| Q2 24 | $-6.1M | $-39.0M | ||
| Q1 24 | $11.9M | $-62.5M |
自由现金流
FPI
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | $-23.1M | ||
| Q2 25 | — | $-22.6M | ||
| Q1 25 | — | $-35.3M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $-30.1M | ||
| Q2 24 | — | $-41.0M | ||
| Q1 24 | — | $-63.3M |
自由现金流率
FPI
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | -118.1% | ||
| Q2 25 | — | -103.6% | ||
| Q1 25 | — | -86.6% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -136.4% | ||
| Q2 24 | — | -182.2% | ||
| Q1 24 | — | -138.9% |
资本支出强度
FPI
LAB
| Q4 25 | — | — | ||
| Q3 25 | — | 4.5% | ||
| Q2 25 | — | 8.7% | ||
| Q1 25 | — | 12.4% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 8.6% | ||
| Q1 24 | — | 1.7% |
现金转化率
FPI
LAB
| Q4 25 | 0.81× | — | ||
| Q3 25 | -4.04× | — | ||
| Q2 25 | -0.29× | — | ||
| Q1 25 | 3.12× | — | ||
| Q4 24 | 0.27× | — | ||
| Q3 24 | -2.39× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 8.66× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FPI
暂无分部数据
LAB
| Consumables | $8.7M | 45% |
| Services And Other Revenue | $5.8M | 29% |
| Instruments | $5.1M | 26% |